Esperion Therapeutics Inc (ESPR) valuation · rev $403.1M
Esperion Therapeutics Inc (ESPR) rev $403.1M.
| Metric | Value |
|---|---|
| Market cap | $816.9M |
| Revenue | $403.1M |
| P/S | 2.0 |
| P/B | 98.4 |
ESPR valuation FAQ
What is ESPR's market cap?
Esperion Therapeutics Inc (ESPR) market cap is $816.9M on the latest cached fundamentals snapshot.
What is ESPR's latest revenue?
Latest cached Esperion Therapeutics Inc (ESPR) revenue was $403.1M. Statements: https://lician.com/financials/espr
What is ESPR's price-to-sales ratio?
Esperion Therapeutics Inc (ESPR) price-to-sales (P/S) is 2.0, cached market cap $816.9M divided by revenue $403.1M.
What is ESPR's price-to-book ratio?
Esperion Therapeutics Inc (ESPR) price-to-book (P/B) is 98.4 on the latest cached fundamentals snapshot.
How many ESPR valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for Esperion Therapeutics Inc (ESPR): Market cap, Revenue, P/S, and P/B.
Where is ESPR valuation listed?
Cached valuation multiples for Esperion Therapeutics Inc (ESPR) are listed at https://lician.com/valuation/espr.
Not investment advice. Cached rows, not a live tape.